Catalog record · Compliance & Regulatory
Stage as of source date not established · historical report, not live reconfirmation.
Eli Lilly automated patient narratives
Vendor workflow source. A reviewed supplier account names the customer and workflow. Supplier attribution and deployment claims are not independent outcome validation.
Last researched Oct 26, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
Lilly deployed natural-language generation to draft patient narratives for clinical study reports.
- Reported stage
- Production
- Technology
- NLP
- Business function
- Back Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 26, 2026
Measures & evidence
2,300 narratives in year one
Original metric claim
Measurement window not disclosed
Scope, baseline & source
- Scope / denominator
- Measurement population / workflow scope not disclosed
- Baseline
- Not disclosed in this account
- Claim basis
- Vendor case; deployment volume, not independently verified quality.
Source-reported claim; methodology, baseline and independent validation may be undisclosed. Inspect the research dossier.
Original prose retained. A single comparable value or unit has not been established.
Read dossier source ↗Exact claim-to-source location has not been mapped. This link belongs to the research dossier.
Measures retain their original currency, scope and period. Capacity, adoption and forecasts are not realized cash savings.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Vendor case reports 2,300 narratives completed in the first year; other document types are separate pilots. Status date not established.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Vendor case page describes hybrid NLG today; exact model mix for the historical Lilly deployment is not established. Do not automate allegation, filing or adjudication decisions. Validate chronology, omissions and template changes.
Potential FS application · inferred
Inferred: Generate standardized suspicious-activity case chronologies or audit-exception narratives from analyst-validated facts.
NLG maps structured facts to consistent narrative templates, reducing copying between records and reports.
Original industry: Pharmaceuticals and biotechnology. Transfer limits: Do not automate allegation, filing or adjudication decisions. Validate chronology, omissions and template changes.
Recorded dependencies
- Traceable source data and approved document/control schemas
- Qualified human review and local testing of accuracy, omissions and full workflow effort
Source register
- The Road to an Automated Clinical Document Landscape at Eli Lillyyseop.com · opens in a new tab
Yseop · vendor-case · full-text · Publication date not recorded
Research lanes: health_life_sciences · Batch global-discovery-2026-10-26. Coverage and remaining gaps